Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassium carbonate is an inorganic salt (K2CO3) with diverse applications. In a clinical setting, it has been evaluated as a ceruminolytic for the removal of earwax, addressing conditions like hearing loss, vertigo, and ear infections. Beyond its medical use, potassium carbonate serves as an activating agent in the synthesis of activated biocarbons for CO2 capture, a base-catalyst in various organic synthesis reactions (e.g., silsesquioxane derivatives, benzothiophene derivatives, fullerene derivatives), and a stabilizing element for thermochemical energy storage materials. It is also utilized in CO2 sensing technologies, as a precipitating agent for calcium carbonate microspheres, and has been studied for its effects in poultry and equine diets as a potassium source and buffer. It is also used as a dietary potassium supplement to address low blood potassium levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Potassium carbonate.